| abstract |
Human relaxin analogs with human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, modified A and / or B chains are described. Also disclosed are nucleic acid sequences encoding human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, and human relaxin analogs. Further disclosed are methods for the treatment of conditions responsive to administration of H3 relaxin or analogs thereof. |